March 1, 2014

Bispecific drug discovery agreement with Sumitomo Dainippon Pharma Co., Ltd

Exscientia is pleased to announce its first collaboration with a Japanese pharmaceutical company, Sumitomo Dainippon Pharma Co., Ltd. This agreement builds on three earlier agreements with US based pharmaceutical companies. Financial terms were not disclosed.

Liked the article? Let’s share it!